Skip to main content
SpringerLink
Log in

Induction of lymphokine-activated killer activity in mice by prothymosin α

  • Short Communication
  • Prothymosin α, NK and LAK Activity, TNFα, IL-2
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

We have recently demonstrated that prothymosin α (ProTα) when administered intraperitoneally (i.p.) protects DBA/2 mice against the growth of syngeneic leukemic L1210 cells through the induction of tumoricidal peritoneal cells producing high levels of tumor necrosis factor α (TNFα) [Papanastasiou et al. (1992) Cancer Immunol Immunother 35: 145]. In this report we tested further immunological alterations that may be caused by the administration of ProTα in vivo. We demonstrate that i.p. injections of ProTα enhance natural killer (NK) cell activity and induce lymphokine-activated (LAK) activity in vivo. Thus, splenocytes from ProTα-treated DBA/2 animals exhibited significantly higher cytotoxic activity (up to threefold) against the NK-sensitive YAC cell line and the NK-resistant P815 and L1210 syngeneic tumor cells, as compared to splenocytes from syngeneic control mice. The enhancement of the cytotoxic profile of DBA/2 splenocytes was associated with increased percentages of CD8+ cells, NK cells and activated CD3+ cells. The ProTα-induced effect persisted for 30 days after the end of the ProTα treatment period and returned to normal levels 20 days later. SPlenocytes from non-treated DBA/2 animals generated high NK and LAK activities in response to ProTα in vitro. The ProTα-induced NK an LAK activities reached 84% and 75% respectively of what was obtained with interleukin-2 (IL-2). High concentrations of TNFα and IL-2 were generated in response to ProTα in LAK cultures. These findings suggest that ProTα may provide an overall protective effect against tumor growth in vivo through induction of NK and LAK activities possibly indirectly via the production of IL-2 and TNFα in the spleen, peritoneal cavity and probably other lymphoid organs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Baxevanis CN, Nagy ZA, Klein J (1981) A novel type of T−T cell interaction remove the requirement for I−B region in the H-2 complex. Proc Natl Acad Sci USA 78: 3809

    PubMed  Google Scholar 

  2. Baxevanis CN, Reclos GJ, Papamichail M, Tsokos GC (1987) Prothymosin α restores the depressed autologous and allogeneic mixed lymphocyte reaction in patients with systemic lupus erythematosus. Immunopharmacol Immunotoxicol 9: 429

    PubMed  Google Scholar 

  3. Baxevanis CN, Reclos GJ, Paneerselvam M, Papamichail M (1988) Enhancement of human T lymphocyte functions by prothymosin α. I. Augmentation of mixed lymphocyte culture reactions and soluble protein-induced-proliferative responses. Immunopharmacology 15: 73

    PubMed  Google Scholar 

  4. Baxevanis CN, Reclos GJ, Papamichail M (1990) Decreased HLA-DR expression on monocytes causes impaired suppressor cell activity in multiple sclerosis. J Immunol 144: 4166

    PubMed  Google Scholar 

  5. Baxevanis, CN, Thanos D, Reclos GJ, Anastasopoulos E, Tsokos GL, Papamatheakis J, Papamichail M (1992) Prothymosin α enhances human and murine major histocompatibility complex class II surface antigen expression and mRNA accumulation. J Immunol 148: 1979

    PubMed  Google Scholar 

  6. Baxevanis CN, Reclos GJ, Papamichail M (1993) Prothymosin α restores depressed allogeneic cell-mediated lympholysis and natural-killer-cell activity in patients with cancer. Int J Cancer 53: 264

    PubMed  Google Scholar 

  7. Chouaib S, Bertoglio G, Blay J-Y, Marchid-Fournigault C, Fradelizi D (1988) Generation of lymphokine-activated killer cells: synergy between tumor necrosis factor and interleukin 2. Proc Natl Acad Sci USA 85: 6875

    PubMed  Google Scholar 

  8. Eschenfeldt WH, Berger SL (1986) The human prothymosin α gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA. Proc Natl Acad Sci USA 83: 9

    PubMed  Google Scholar 

  9. Fujiwara T, Grimm EA (1992) Regulation of lymphokine-activated killer cell induction by human recombinant IL-1 receptor antagonist. J Immunol 148: 2941

    PubMed  Google Scholar 

  10. Gallacher G, Stimson WH, Findlay J, Al-Azzawi F (1990) Interleukin-6 enhances the induction of human lymphokine-activated killer cells. Cancer Immunol Immunother 31: 49

    PubMed  Google Scholar 

  11. Gately M, Wolitzky AG, Quinn PM, Chizzonite R (1992) Regulation of human cytolytic lymphocyte responses by interleukin-12. Cell Immunol 143: 127

    PubMed  Google Scholar 

  12. Goodall GJ, Dominquez F, Horecker BL (1986) Molecular cloning of cDNA for human prothymosin α. Proc Natl Acad Sci USA 83: 8926

    PubMed  Google Scholar 

  13. Haritos AA, Goodall GJ, Horecker BL (1984) Prothymosin α: isolation and properties of the major immunoreactive form of thymosin α1 in rat thymus. Proc Natl Acad Sci USA 81: 1008

    PubMed  Google Scholar 

  14. Haritos AA, Tsolas O, Horecker BL (1984) Distribution of prothymosin α in rat tissues. Proc Natl Acad Sci USA 81: 1391

    PubMed  Google Scholar 

  15. Haritos AA, Salvin BB, Blacher R, Stein S, Horecker BL (1985) Parathymosin α: a peptide from rat tissues with structural homology to prothymosin α. Proc Natl Acad Sci USA 82: 1050

    PubMed  Google Scholar 

  16. Jackson AM, Hawkyard SJ, Prescott, S, Ricchie AW, James K, Chisholm GD (1992) An investigation of factors influencing the in vitro induction of LAK activity against a variety of human bladder cell lines. J Urol 147: 207

    PubMed  Google Scholar 

  17. Lotzova E (1989) Analysis of effector mechanisms in cancer. Curr Opin Immunol 1: 904

    PubMed  Google Scholar 

  18. Lotzova E, Herberman RB (1987) Reassessment of LAK phenomenology: a review. Nat Immun Cell Growth Regul 6: 109

    PubMed  Google Scholar 

  19. Matossian-Rogers A, Browne C, Turkish M, O'Byrne P, Festenstein H (1989) Tumor necrosis factor-alpha enhances the cytolytic and cytostatic capacity of interleukin-2 activated killer cells. Br J Cancer 59: 573

    PubMed  Google Scholar 

  20. Mule JJ, Custer MC, Travis WD, Rosenberg SA (1992) Cellular mechanisms of the antitumor activity of recombinant IL-6 in mice. J Immunol 148: 2622

    PubMed  Google Scholar 

  21. Mule JJ, Marcus SG, Yang JC, Weber JS, Rosenberg SA (1992) Clinical application of IL-6 in cancer therapy. Res Immunol 143: 777

    PubMed  Google Scholar 

  22. Naume B, Gately M, Espevik T (1992). A comparative study of IL-12-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells. J Immunol 148: 2429

    PubMed  Google Scholar 

  23. Pan L-X, Haritos AA, Wideman J, Komiyama T, Chang M, Stein S Salvin SB, Horecker BL (1986) Human prothymosin α: amino acid sequence and immunologic properties. Arch Biochem Biophys 250: 197

    PubMed  Google Scholar 

  24. Papamichail M, Baxevanis CN (1992) Gamma-interferon enhances the cytotoxic activity of interleukin-2-induced peripheral blood lymphocyte (LAK) cells, tumor infiltrating lymphocytes (TIL), and effusion associated lymphocytes. J Chemother 4: 387

    PubMed  Google Scholar 

  25. Papanastasiou M, Baxevanis CN, Papamichail M (1992) Promotion of murine antitumor activity by prothymosin α treatment. I. Induction of tumoricidal peritoneal cells producing high levels of tumor necrosis factor α. Cancer Immunol Immunother 35: 145

    PubMed  Google Scholar 

  26. Reclos GC, Baxevanis CN, Sfagos C, Papageorgiou C, Tsokos GC, Papamichail M (1987) Multiple sclerosis. II. Effects of prothymosin α on the autologous and allogeneic MLR in patients with multiple sclerosis. Clin Exp Immunol 70: 336

    PubMed  Google Scholar 

  27. Reiter Z, Ozes ON, Blatt LM, Taylor MW (1992) A dual antitumor effect of a combination of interferon-α or interleukin-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicity. Clin Immunol Immunopathol 62: 103

    PubMed  Google Scholar 

  28. Smyth MJ, Ortaldo JR (1991) Comparison of the effect of IL-2 and IL-6 on the lytic activity of purified human peripheral blood large granular lymphocytes. J Immunol 146: 1380

    PubMed  Google Scholar 

  29. Takai Y, Wong GG, Clark SC, Burkoff SJ, Herrman SH (1988) B-cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol 140: 508

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology, Hellenic Anticancer Institute, 171 Alexandras Ave., 11522

    Constantin N. Baxevanis, Angelos D. Gritzapis, George V. Z. Dedoussis, Nikolaos G. Papadopoulos & Michael Papamichail

  2. Laboratory of Biological Chemistry, University of Ioannina Medial School, Ioannina, Greece

    Orestes Tsolas

Authors
  1. Constantin N. Baxevanis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angelos D. Gritzapis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. George V. Z. Dedoussis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Nikolaos G. Papadopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Orestes Tsolas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Michael Papamichail
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This work was supported by a CEC grant to M. Papamichail

Rights and permissions

Reprints and permissions

About this article

Cite this article

Baxevanis, C.N., Gritzapis, A.D., Dedoussis, G.V.Z. et al. Induction of lymphokine-activated killer activity in mice by prothymosin α. Cancer Immunol Immunother 38, 281–286 (1994). https://doi.org/10.1007/BF01533521

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01533521

Key words

Search

Navigation